JP2022527025A5 - - Google Patents
Info
- Publication number
- JP2022527025A5 JP2022527025A5 JP2021560413A JP2021560413A JP2022527025A5 JP 2022527025 A5 JP2022527025 A5 JP 2022527025A5 JP 2021560413 A JP2021560413 A JP 2021560413A JP 2021560413 A JP2021560413 A JP 2021560413A JP 2022527025 A5 JP2022527025 A5 JP 2022527025A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- administration
- compound according
- formula
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828995P | 2019-04-03 | 2019-04-03 | |
| US62/828,995 | 2019-04-03 | ||
| US201962879794P | 2019-07-29 | 2019-07-29 | |
| US62/879,794 | 2019-07-29 | ||
| US201962933632P | 2019-11-11 | 2019-11-11 | |
| US62/933,632 | 2019-11-11 | ||
| PCT/US2020/026732 WO2020206363A1 (en) | 2019-04-03 | 2020-04-03 | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527025A JP2022527025A (ja) | 2022-05-27 |
| JP2022527025A5 true JP2022527025A5 (enExample) | 2023-04-17 |
Family
ID=72666280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560413A Pending JP2022527025A (ja) | 2019-04-03 | 2020-04-03 | 神経変性疾患及びミトコンドリア病の治療のための組成物及びその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220162215A1 (enExample) |
| EP (1) | EP3947390A4 (enExample) |
| JP (1) | JP2022527025A (enExample) |
| KR (1) | KR20220004068A (enExample) |
| CN (1) | CN114026093A (enExample) |
| AU (1) | AU2020253561A1 (enExample) |
| BR (1) | BR112021019802A2 (enExample) |
| CA (1) | CA3135755A1 (enExample) |
| IL (1) | IL286767A (enExample) |
| MX (1) | MX2021012129A (enExample) |
| WO (1) | WO2020206363A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018237145A1 (en) | 2017-06-21 | 2018-12-27 | Mitokinin, Inc. | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
| WO2023023671A1 (en) * | 2021-08-20 | 2023-02-23 | Mitokinin, Inc. | Compositions and methods for treatment of neurodegenerative and mitochondrial disease |
| WO2023023670A1 (en) * | 2021-08-20 | 2023-02-23 | Mitokinin, Inc. | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease |
| WO2024040266A2 (en) * | 2022-08-19 | 2024-02-22 | Mitokinin, Inc. | Disubstituted benzoimidazole and indole analogs as modulators of pink1 |
| EP4620957A1 (en) * | 2024-03-22 | 2025-09-24 | Eberhard Karls Universität Tübingen | Imidazo[4,5-b]pyridin-7-amine compounds binding aurora kinase a and uses thereof |
| CN118290348A (zh) * | 2024-03-22 | 2024-07-05 | 诚达药业股份有限公司 | 一种4-氯吡咯并嘧啶类化合物或其衍生物的合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9613021D0 (en) * | 1996-06-21 | 1996-08-28 | Pharmacia Spa | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| CN101316853B (zh) * | 2005-08-04 | 2014-09-24 | 西特里斯药业公司 | 作为sirtuin调节剂的苯并噻唑和噻唑并吡啶 |
| ES2412384T3 (es) * | 2006-07-18 | 2013-07-11 | Astellas Pharma Inc. | Derivado de aminoindano o sal del mismo |
| AU2014214561C1 (en) * | 2013-02-11 | 2019-01-17 | Mitokinin, Inc. | Compositions and methods for treating neurodegenerative diseases |
| EP2818472A1 (en) * | 2013-06-27 | 2014-12-31 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators |
| ES2919024T3 (es) * | 2014-02-11 | 2022-07-21 | Mitokinin Inc | Composiciones y procedimientos que utilizan las mismas para el tratamiento de enfermedades neurodegenerativas y mitocondriales |
| CN108934162A (zh) * | 2015-12-16 | 2018-12-04 | 南方研究所 | 吡咯并嘧啶化合物、作为激酶lrrk2抑制剂的用途及其制备方法 |
| WO2018065365A1 (en) * | 2016-10-03 | 2018-04-12 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
| WO2018106818A1 (en) * | 2016-12-07 | 2018-06-14 | Kura Oncology, Inc. | Methods of promoting beta cell proliferation |
| WO2018237145A1 (en) * | 2017-06-21 | 2018-12-27 | Mitokinin, Inc. | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
| KR20220158290A (ko) * | 2020-02-21 | 2022-11-30 | 미토키닌, 인크. | 신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법 |
-
2020
- 2020-04-03 EP EP20784272.5A patent/EP3947390A4/en not_active Withdrawn
- 2020-04-03 WO PCT/US2020/026732 patent/WO2020206363A1/en not_active Ceased
- 2020-04-03 CN CN202080040787.8A patent/CN114026093A/zh active Pending
- 2020-04-03 BR BR112021019802A patent/BR112021019802A2/pt not_active Application Discontinuation
- 2020-04-03 AU AU2020253561A patent/AU2020253561A1/en not_active Abandoned
- 2020-04-03 MX MX2021012129A patent/MX2021012129A/es unknown
- 2020-04-03 US US17/601,372 patent/US20220162215A1/en not_active Abandoned
- 2020-04-03 KR KR1020217035783A patent/KR20220004068A/ko not_active Withdrawn
- 2020-04-03 CA CA3135755A patent/CA3135755A1/en active Pending
- 2020-04-03 JP JP2021560413A patent/JP2022527025A/ja active Pending
-
2021
- 2021-09-29 IL IL286767A patent/IL286767A/en unknown
-
2025
- 2025-03-24 US US19/088,609 patent/US20250250276A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534106A5 (enExample) | ||
| JP2021534108A5 (enExample) | ||
| JP2008514732A5 (enExample) | ||
| JP2016506387A5 (enExample) | ||
| KR930019213A (ko) | 간염치료에 유용한 1,3-옥사티올란류 | |
| RU2012110380A (ru) | Новое производное 5-фторурацила | |
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| CA2511479A1 (en) | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | |
| JP2009526831A5 (enExample) | ||
| JP2008526999A5 (enExample) | ||
| JP2009537550A5 (enExample) | ||
| MX2008010187A (es) | Tratamiento de distrofia muscular de duchenne. | |
| HUP0001446A2 (hu) | HIV reverz transzkriptáz inhibitor hatású 4,4-diszubsztituált-3,4-dihidro-2(1H)-kinazolinon-származékok, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
| JP2012519691A5 (enExample) | ||
| CA2481482A1 (en) | Tropane derivatives as ccr5 modulators | |
| JP2002537292A5 (enExample) | ||
| KR927003586A (ko) | 신규한 중추 작용성 6,7,8,9-테트라하이드로-3H-벤즈(e)인돌 헤테로사이클 화합물 | |
| RU2004134719A (ru) | Производные n-ацилпиперидина для применения в качестве лигандов мелатокортиновых рецепторов при лечении пищевых нарушений | |
| JP2022552159A5 (enExample) | ||
| CA2434028A1 (en) | Amino ceramide-like compounds and therapeutic methods of use | |
| JP2006508965A5 (enExample) | ||
| RU2006138426A (ru) | Производные тиазолопиридина, содержащие их фармацевтические композиции и способы лечения состояний, опосредованных глюкокиназой | |
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| JP2005513017A5 (enExample) | ||
| CO5200778A1 (es) | Composicion farmaceutica que comprende una cantidad terapeuticamente efectiva de b enzimidazol, administrada para prevenir y tratar el cancer e inhibir la metastasis |